Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 16, 2007

Applied Biosystems Launches Genotyping Service Provider Program

  • Applied Biosystems has established a global genotyping service. The SNPlex™ service provider program was created for research laboratories that do not have access to capillary electrophoresis genetic analysis instrument systems.

    “The SNPlex service provider program facilitates access to a complete genotyping analysis system for those who have not scaled up their research and made an investment to purchase on their own,” explains Phoebe White, senior director of genotyping, Applied Biosystems.

    The providers in the program include the Chinese National Human Genome Center, DNAVision in Belgium, IntegraGen  in France, Medical Solutions Geneservice in the U.K., the UCLA DNA Sequencing and Genotyping Core Facility, and Vanderbilt University DNA Sequencing and Genotyping Facility.

    Members of the program were chosen based on proficiency in executing the SNPlex chemistry workflow and generating reliable data using GeneMapper™ software for data analysis, according to White.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »